I've shown research before indicating that excess deaths for all-cause mortality are running about 10% higher than they were before covid, and that some covid-related deaths are running 80% higher for those indications. I've been hoping that Humanigen uses this data to accurately depict the risk/benefit associated with the Approval of Lenzilumab.
Now, the Czech Republic is reporting adverse conditions on the other side of the spectrum, that being a decrease in successful conceptions (SC).
"Rates of successful conceptions according to COVID-19 vaccination status: Data from the Czech Republic...
The Comirnaty (Pfizer-BioNTech) and Spikevax (Moderna) mRNA vaccines comprised 96% of all administered COVID-19 vaccine doses...
Conclusion We conclude that at least from June 2021, SC rates in the Czech Republic for women vaccinated against COVID-19 before SC were substantially lower than for those who were unvaccinated before SC."